PMGC HOLDINGS INC. Depreciation
PMGC HOLDINGS INC. (ELAB) reported Depreciation of $479.31 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-14
- PMGC HOLDINGS INC. depreciation for the quarter ending 2026-06-30 was $305.40K, a 1454200.00% increase year-over-year.
- PMGC HOLDINGS INC. depreciation for the quarter ending 2026-03-31 was $173.90K, a 10762.21% increase year-over-year.
- PMGC HOLDINGS INC. depreciation for the quarter ending 2025-12-31 was $59.76K, a 1747.20% increase year-over-year.
- PMGC HOLDINGS INC. depreciation for the quarter ending 2025-09-30 was $35.28K, a 989.68% increase year-over-year.
- PMGC HOLDINGS INC. depreciation for fiscal 2025 was $96.66K, a 646.43% increase from fiscal 2024.
- PMGC HOLDINGS INC. depreciation for fiscal 2024 was $12.95K, a 11.17% increase from fiscal 2023.
- PMGC HOLDINGS INC. depreciation for fiscal 2023 was $11.65K, a 78.89% increase from fiscal 2022.
- PMGC HOLDINGS INC. depreciation for fiscal 2022 was $6.51K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $305.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $479.31K 10-Q · filed 2026-08-14 | $539.06K derived: sum of 3 quarters · filed 2026-08-14 | $574.35K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $173.90K 10-Q · filed 2026-05-15 | $233.66K derived: sum of 2 quarters · filed 2026-05-15 | $268.94K derived: sum of 3 quarters · filed 2026-05-15 | $268.97K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $59.76K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $95.04K derived: sum of 2 quarters · filed 2026-03-30 | $95.06K derived: sum of 3 quarters · filed 2026-08-14 | $96.66K 10-K · filed 2026-03-30 | ||
| 2025-09-30 | $35.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $35.30K derived: sum of 2 quarters · filed 2026-08-14 | $36.91K 10-Q · filed 2025-11-14 | $40.14K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $21.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.62K 10-Q · filed 2026-08-14 | $4.86K derived: sum of 3 quarters · filed 2026-08-14 | $8.10K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $1.60K 10-Q · filed 2026-05-15 | $4.84K derived: sum of 2 quarters · filed 2026-05-15 | $8.07K derived: sum of 3 quarters · filed 2026-05-15 | -$6.64K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $3.23K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $6.47K derived: sum of 2 quarters · filed 2026-03-30 | -$8.24K derived: sum of 3 quarters · filed 2026-03-30 | $12.95K 10-K · filed 2026-03-30 | ||
| 2024-09-30 | $3.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$11.47K derived: sum of 2 quarters · filed 2025-11-14 | $9.71K 10-Q · filed 2025-11-14 | $12.63K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | -$14.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $6.48K 10-Q · filed 2025-08-13 | $45.96K 10-Q · filed 2024-08-14 | $9.39K derived: sum of 3 quarters · filed 2025-08-13 | $12.30K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $21.19K 10-Q · filed 2025-05-14 | $24.10K derived: sum of 2 quarters · filed 2025-05-14 | $27.01K derived: sum of 3 quarters · filed 2025-05-14 | $29.93K derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $2.91K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $5.82K derived: sum of 2 quarters · filed 2025-03-28 | $8.74K derived: sum of 3 quarters · filed 2025-03-28 | $11.65K 10-K · filed 2025-03-28 | ||
| 2023-09-30 | $2.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $5.83K derived: sum of 2 quarters · filed 2024-11-14 | $8.74K 10-Q · filed 2024-11-14 | $8.74M 10-Q · filed 2023-12-11 | -$3.88M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $2.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $5.83K 10-Q · filed 2024-08-14 | -$3.89M derived: sum of 3 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $2.91K 10-Q · filed 2024-05-15 | -$3.89M derived: sum of 2 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $6.51K 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | $3.90M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |